Explained: Why UBS expects Shaily Engineering shares to rise another 43%

UBS said Swiss generic medicines maker Sandoz has received approval to launch generic semaglutide in Canada, with the drug set to be launched in three strengths through a pen format. This is positive for Shaily Engineering Plastics given its dominant share in the Canadian pen market.